Global Cephalosporin Market Research Report 2022 - Market Size, Current Insights and Development Trends

Cephalosporin are bactericidal beta lactam antibiotics. These prevent the growth of bacteria by inhibiting cell wall synthesis, which effective in both type of bacteria i.e., gram-positive and gram-negative. Cephalosporin drugs are considered broad-spectrum antibiotics having similar activities to those of ampicillin and often are considered an alternative to penicillin for many patients. Cephalosporin drugs are used to treat infections in different parts of the body such as lungs, ears, sinuses, nose, throat, and skin. Physicians also prescribe these drugs to treat pneumonia, staph infections, bronchitis, strep throat, tonsillitis, and gonorrhea.
The Cephalosporin market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Cephalosporin market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Cephalosporin market.

Major Players in the Cephalosporin market are:
Lupin Pharmaceuticals
Hospira
Shionogi
Allergan
Teva
Theravance Biopharma
Wockhardt.
Bristol-Myers Squibb
Basilea Pharmaceuticals
F. Hoffmann-La Roche
AstraZeneca
Flynn Pharma
GSK
Aurobindo Pharma
Orchid Pharma
Johnson & Johnson
Eli Lilly
Aspen Pharmacare
Par Pharmaceutical
Merck
Incepta Pharmaceuticals
Pernix Therapeutics
Pfizer
Sanofi
Baxter
Takeda Pharma
Abbott
Astellas
Kyorin Pharmaceutical
Sandoz
Corden Pharma
Sun Pharmaceutical

On the basis of types, the Cephalosporin market is primarily split into:
Injection
Oral

On the basis of applications, the market covers:
Respiratory Tract Infection
Skin Infection
Ear Infection
Urinary Tract Infection
Sexually Transmitted Infection
Others

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029